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A B S T R A C T
We described the use of a new chemical substance Sodium nucleinate (SN) as an immunomodulatory substance exhibit-
ing antiinflammatory properties. Sodium nucleinate (SN) registrated in Russian Federation as Tamerit®, is 2-amino-
-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, derivative of well known chemical substance luminol.
To comprehend the mechanisms of SN immunomodulatory activity, we examined the SN modulation of the oxidative
burst responses of whole blood human monocytes and polimorphonuclear cells (PMC) stimulated with phorbol 12-myri-
state 13-acetate (PMA) or E. coli suspension in vitro. SN did not inhibit the proportion of neutrophils and monocytes
phagocytosing E. coli. Oxidative burst responses of monocytes stimulated with PMA were strongly inhibited at SN con-
centration ranging from 10–500 mg/ml, less efficient inhibitor was SN in E. coli stimulated monocytes (inhibition range
was from 50–500 mg/ml SN). SN inhibited PMC oxidative burst only in range 100–500 mg/ml SN. In conclusion, we
found SN as an efficient inhibitor of oxidative burst in monocytes. Since ROS generation in monocytes/macrophages has
been found to be important for LPS-driven production of several proinflammatory cytokines, SN may exsert its anti-
inflammatory effects through monocyte/macrophage oxidative burst inhibition.
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Introduction
Neutrophils and monocytes/macrophages play an im-
portant role in non-specific immune response and organ-
ism resistance, specifically in anti-bacterial resistance
and as effectors, inducing and regulating immune cells1.
Free oxygen radicals kill bacteria in phagosomes and par-
tially are released into the environment, intensifying
killing microorganisms and simultaneously injuring the
surrounding tissues. It is specifically intensified in acute
inflammation, less in chronic course of the disease2,3.
Active oxygeninduced and free-radical-mediated oxi-
dation of biological molecules, membranes, and tissues is
closely related to a variety of inflammatory diseases.
Once free radicals are produced, they multiply geometri-
cally in chain reactions unless they are quenched by anti-
oxidants or other free-radical scavengers. Antioxidants
are compounds that react with free radicals and protect
neighboring structures from oxidant damage. Common
protective antioxidant nutrients include vitamins C, E,
and P-carotene, however their action is limited due to their
low capacity to enter tissue and cell compartments3,4.
This study was performed to determine whether So-
dium Nucleinate (SN; 2-amino-1,2,3,4-tetrahydrophtha-
lazine-1,4-dione sodium salt dihydrate, derivative of well
known chemical substance luminol)) registrated in Rus-
sian Federation as antiinflammatory drug Tamerit®, but
in EU or USA not avaliable until recently, may play a role
as inhibitor of respiratory burst in polymorphonuclear
cells (PMCs) and/or monocytes. In previous study we
demonstrated that SN is an efficient inhibitor of sepsis
development in mice model of LPS-induced sepsis3. The
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changes induced by SN included decreased mice plasma
inflammatory cytokine production. Similarly we demon-
strated a decreased TNF-a, IFN-g and IL-6 response in
human LPS-stimulated PBMNCs.
Several authors have recently confirmed that ROS
are important for normal lipopolysaccharide (LPS)-dri-
ven production of several proinflammatory cytokines
and for the enhanced responsiveness to LPS seen in cells
from patients with chronic inflammatory diseases4,5. Mul-
tiple cytokine secretion may be triggered by a vast num-
ber of pathological conditions, many of them begin with
activation of PMNs and/or monocytes4,5.
Since ROS was found to be important for lipopolysac-
charide (LPS)-driven production of several proinflam-
matory cytokines, we have focused on the in vitro influen-
ce of the SN when applied in blood samples stimulating
with agonists leading to an activation of respiratory
burst in PMCs and/or monocytes.
Materials and Methods
Blood samples
Peripheral blood samples were drawn from 9 healthy
individuals after obtaining their signed informed con-
sents.
Phago-Burst Test
Phagocytosis and oxidative burst capacity was measu-
red using Phago-Burst test (Orphegen Pharma, 341060+
341058, Heidelberg, Germany). Whole blood test samples
were divided into six plastic test tubes (BD, Falcon,
353052) in volume of 100 ml. All the tubes were held in
ice bath during the preparation of the test. The test re-
agents were added as follows: in the first tube FITC la-
belled E. coli (phagocytosis control – FK); in the second
FITC labelled E. coli (phagocytosis test – FT); in the
third wash solution and 123 dihydrorhodamin (wash so-
lution control); in the fourth unlabeled stimulating opso-
nized E. coli and 123 dihydrorhodamin (E. coli stimu-
lated test – EC); in the fifth fMLP and 123 dihydro-
rhodamin (fMLP stimulated control – FMLP); and in the
sixth PMA (phorbol myristate acetate) and 123 dihy-
drorhodamin (PMA stimulated test – PMA). Tube 1 was
incubated at 0°C (FK) and all others on 37°C for 10 min-
utes. Whole blood test samples were then lysed with
lysing solution and washed three times with wash solu-
tion. Cells were than stained with propidium iodide.
Measuring was performed using flow cytometer (BD,
FACSort, USA) equipped with argon-ion laser of 488 nm
excitation wavelength.
FITC labeled E. coli suspension
FITC labeled E. coli (Phago-Burst test (Orphegen
Pharma, Heidelberg, Germany) were used for the stimu-
lation of monocytes/PMC. E. coli suspension (5´107/ml)
was quantitated by using Cell Viability Kit with Liquid
Counting Beads (BD Biosciences). The kit contains a liq-
uid suspension of fluorescent beads, which are added to
the flow sample to calculate absolute counts of bacterial
suspension.
Statistical analysis
Descriptive statistics were calculated for all the mea-
sured parameters. Differences between control and SN
pre-treated samples were tested both using paired t-test
and exact Wilcoxon signed-rank matched-pairs test
(EWMPT). Differences were taken as statistically signifi-
cant if p<0.05. Statistical analyses were performed using
SPSS for Windows 15.0.1.1 software (SPSS Inc., Chicago,
IL, 2007).
Results
Phagocytic activity of monocytes/neutrophils
The ability of neutrophils to phagocytize opsonized E.
coli was assessed. No inhibitory effects of SN (range
0.1–500 mg/ml) were found in monocytes/PMC stimulat-
ing either with PMA or E. coli in vitro (data not shown).
Inhibitory effects of SN on monocyte/neutrophil
oxidative burst
To determine the effect of SN on oxidative burst of
monocytes/MNCs blood was preincubated with 0 (con-
trol), 0.1, 10, 50, 100 and 500 mg/ml of SN for 10 min.
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Fig. 1. Dose effect for the inhibition induced by SN on the monocyte oxidative burst in PMA and E. coli stimulated blood. Data are pre-
sented as X±SD (N=9). SN was added to whole blood 10 min before phago-burst test. Monocyte oxidative burst activity of normal blood
(Neg control,) and blood containing SN in concentrations 0.1; 1; 10; 50 and 500 mg/ml). * p<0.05; ** p<0.01.
Blood was then stimulated with PMA or E. coli suspen-
sion (5´107/ml). We assessed the effects of SN on mono-
cyte/PMC oxidative burst activity as measured by the
conversion of DHR 123 to rhodamine 123. When com-
pared to PMA-activated monocytes which were cultured
alone, monocytes preincubated with SN showed a signifi-
cant decrease in oxidative burst activity (Figure 1). Oxi-
dative burst responses of monocytes stimulated with
PMA were strongly inhibited at SN concentration rang-
ing from 10–500 mg/ml, however SN was less efficient in-
hibitor in E. coli stimulated monocytes (inhibition range
was from 50–500 mg/ml SN). SN inhibited PMC oxida-
tive burst only in very high concentration range (100 and
500 mg/ml SN).
Discussion
The oxidative burst assay employed in this study uti-
lizes dichlorofluorescein diacetate as a fluorescent probe.
This assay detects mainly superoxide anion and hydro-
gen peroxide, and to a lesser extent, other reactive oxy-
gen species such as hydroxyl radicals4. The inhibition of
oxidative burst by SN would suggest its ability to scav-
enge superoxide anion and hydrogen peroxide.
In the previous study, we first demonstrated that SN
is an efficient inhibitor of sepsis development in mice
model of LPS-induced sepsis. The changes induced by
SN include decreased mice plasma inflammatory cyto-
kine production. Similarly we demonstrated a decreased
TNF-a, IFN-g and IL-6 response in human LPS-stimu-
lated PBMNCs. SN was therefore shown to be a promis-
ing inhibitor of multiple inflammatory cytokine secretion.
Inflammatory mediators, cytokines (e.g. TNF-a) in-
crease the ability of monocytes/PMC to localize at the
site of inflammation. Phagocytic ability is elevated by in-
tensification of hydroxylic radical production and lyso-
somal enzyme release (6). TNFa is an important factor
strengthening granulocyte phagocytic and cytotoxic ac-
tivity. Activated monocytes and granulocytes secrete cy-
tokines. IL-1, which stimulates monocytes, endothelial
cells, and fibroblasts to secrete IL-8, in turn increases the
expression of CD11b/CD18 adhesive molecules and gra-
nulocyte oxygen metabolism7,8.
This study was performed to determine whether SN
may exert the anti-inflammatory effects by acting as as
inhibitor of respiratory burst in PMCs and/or monocytes.
Stimulation of monocytes/PMCs by phorbol 12-myristate
13-acetate (PMA) results in induction of superoxide an-
ion production through assembly of the NADPH-oxidase
complex. This so-called respiratory burst is fundamen-
tally important in monocytes/PMC since it is implicated
in the killing of microbial intruders and in the tissue
damage secondary to the induced inflammatory respon-
se9. The activation status of monocytes/PMCs can range
from quiescent over primed to fully activated10.
To determine the effect of SN on oxidative burst of
monocytes/MNC blood was preincubated with 0 (Control),
0.1, 10, 50, 100 and 500 mg/ml of SN for 10 min. We as-
sessed the effects of SN on monocyte/PMC oxidative burst
activity as measured by the conversion of DHR 123 to
rhodamine 123. Blood was incubated without or with SN
and after 10 min whole blood was stimulated with PMA or
E. coli suspension (5´107/ml). When compared to mono-
cytes which were cultured alone, PMA-activated mono-
cytes showed a significant decrease in oxidative burst ac-
tivity. Oxidative burst responses of monocytes stimulated
with PMA were strongly inhibited at SN concentration
ranging from 10–500 mg/ml. SN was less efficient inhibi-
tor in E. coli stimulated monocytes (inhibition range was
from 50–500 mg/ml SN). On contrary SN inhibited PMC
oxidative burst only in range 100–500 mg/ml SN, that con-
centration of SN is probably a lot over the achievable
range during therapy and inhibitory effects may be a con-
sequence of some relatively unspecific process.
We found SN as an efficient inhibitor of oxidative
burst in monocytes. The data from this study are encour-
aging as researchers across the world are searching for
ways to prevent the development of free-radical-medi-
ated disorders such as atherosclerosis, arthritis, cancer,
and aging11,12. Furthermore our data may also explain in-
triguing clinical data described in Russian pharmacopeia
where SN is declared as a potent anti-inflammatory drug
with excellent body-distribution and minimal side ef-
fects3. As we found SN effective mainly as a potent ROS
scavenger in strongly activated monocytes (by PMA as
strong ROS activator), SN may exsert its antiinflamma-
tory effects through oxidative burst inhibition in stron-
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Fig. 2. Dose effect for the inhibition induced by SN on the PMC oxidative burst in PMA and E. coli stimulated blood. Data are presented
as X±SD (N=9). SN was added to whole blood 10 min before phago-burst test. PMC oxidative burst activity of normal blood (Neg con-
trol,) and blood containing SN in concentrations 0.1; 1; 10; 50 and 500 mg/ml). * p<0.05; ** p<0.01.
gly activated monocytes/macrophages13. Since ROS gen-
eration in monocytes/macrophages has been found by
many authors to be important for LPS-driven production
of several proinflammatory cytokines, the antiinflama-
tory action of SN may be a consequence of ROS inhibi-
tion in activated monocytes/macrophages2,13,14. Although
SN used as a drug is widely distributed within tissues
and cells through the body, its ROS scavenger function is
phisiologically important mainly in cells where ROS pro-
daction reaches substantial levels, e.g. in monocytes/ma-
crophages and neutrophils.
Side effects of SN may be therefore expected in inhibi-
tion od neutrophil killing of bacteria, an essential process
in defence against infectious agents. However, we as-
sesed the ability of neutrophils to phagocytize opsonized
E. coli was assessed. No inhibitory effects of SN (range
0,1–500 mg/ml) were found in monocytes/PMC stimulat-
ing either with PMA or E. coli in vitro. On the other
hand, SN inhibited PMC oxidative burst only in range
100–500 mg/ml SN, that concentration of SN is probably
a lot over the achievable range during therapy. It is
therefore probable that SN does not affect neutrophil
killing of bacteria while it is capable to act as ROS scav-
enger and anti-inflammatory agent in monocytes/mac-
rophages3,4.
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TETRAHIDROFTALAZINSKI DERIVAT »NATRIJ NUKLEINAT« ISPOLJAVA PROTUUPALNO
DJELOVANJE KROZ INHIBICIJU OKSIDATIVNE AKTIVNOSTI HUMANIH MONOCITA
S A @ E T A K
Opisali smo kori{tenje nove kemijske tvari Natrij nukleinata (SN) kao imunomodulatorne tvari koja pokazuje protu-
upalna svojstva. Natrij nucleinat (SN) registriran u Ruskoj Federaciji kao Tamerit® je 2-amino-1,2,3,4-tetrahidroftala-
zin-1,4-dion dihidrat natrijeve soli, derivat poznate kemijske tvari luminol. Da bi shvatiti mehanizme SN imunomodu-
latorne aktivnosti, ispitali smo SN modulaciju naglog oksidativnog odgovora monocita i polimorfonuklearnih stanica
(PMC) cijele ljudske krvi stimuliranih s forbol-12-miristat-13-acetatom (PMA) ili E. coli suspenzijom in vitro. SN nije
sprije~io udio neutrofila i monocita u fagocitiranju E. coli. Nagli oksidativni odgovori monocita stimuliranih s PMA
sna`no su inhibirani sa SN u rasponu koncentracija od 10–500 mg/ml, manje u~inkoviti inhibitor je SN u monocita
stimuliranih s E. Coli (inhibicijski raspon od 50–500 mg/ml SN). SN je inhibirao PMC oksidativni odgovor samo u
rasponu od 100–500 mg/ml. Kao zaklju~ak, otkrili smo da je SN u~inkoviti inhibitor naglog oksidativnog odgovora u
monocita. Od kako se pokazalo da je produkcija ROS u monocitima/makrofaga va`na za LPS-potaknutu proizvodnju
nekoliko proupalnih citokina, SN mo`e vr{iti svoje protuupalno djelovanje kroz inhibiciju monocitnog/makrofagnog
naglog oksidativnog odgovora.




ROS – reactive oxigen species
PBMNC – peripherial blood mononuclear cell
PMC – polymorphomononuclear cell
TNF-a – tumor necrosis factor alpha
IFN-g – gamma interferon
IL-6 – interleukin 6
